Home » Amag Falls as Safety Risks Cloud Kidney Drug’s Future
Amag Falls as Safety Risks Cloud Kidney Drug’s Future
AMAG Pharmaceuticals’ shares fell 21 percent to their lowest in nearly five years after it found ‘life-threatening’ events associated with its key drug, Feraheme, throwing into doubt the drugs future sales.
Finanz Nachrichten
Finanz Nachrichten
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct